M&A Deal Summary

UDG Healthcare Acquires Daiichi Sankyo - Pharmaceutical Packaging Facility

On April 3, 2017, UDG Healthcare acquired real estate company Daiichi Sankyo - Pharmaceutical Packaging Facility from Daiichi Sankyo for 14M USD

Acquisition Highlights
  • This is UDG Healthcare’s 1st transaction in the Real Estate sector.
  • This is UDG Healthcare’s 19th largest (disclosed) transaction.
  • This is UDG Healthcare’s 7th transaction in the United States.
  • This is UDG Healthcare’s 4th transaction in Pennsylvania.

M&A Deal Summary

Date 2017-04-03
Target Daiichi Sankyo - Pharmaceutical Packaging Facility
Sector Real Estate
Buyer(s) UDG Healthcare
Sellers(s) Daiichi Sankyo
Deal Type Divestiture
Deal Value 14M USD

Target

Daiichi Sankyo - Pharmaceutical Packaging Facility

Bethlehem, Pennsylvania, United States
Daiichi Sankyo Co. Ltd. - Pharmaceutical Packaging Facility comprises 146,000 sq ft pharmaceutical grade packaging facility will offer additional packaging capacity under the experienced management team and serialization leadership of Sharp’s nearby Allentown campus.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

UDG Healthcare

Dublin, Ireland

Category Company
Founded 1948
Sector Business Services
Employees9,000
Revenue 1.3B USD (2020)
DESCRIPTION

UDG Healthcare operates in two segments, Ashfield and Sharp. Ashfield is a global integrated healthcare services partner offering a breadth of services in advisory, marketing, communications, strategic engagement, and patient solutions. Sharp engages in contract packaging, clinical, manufacturing, and technology services. UDG Healthcare was founded in 1948 and is based in Dublin, the Republic of Ireland.


DEAL STATS #
Overall 24 of 32
Sector (Real Estate) 1 of 1
Type (Divestiture) 4 of 5
State (Pennsylvania) 4 of 5
Country (United States) 7 of 13
Year (2017) 1 of 5
Size (of disclosed) 19 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-21 STEM Marketing

London, United Kingdom

STEM Marketing Ltd. is a global provider of commercial, marketing and medical audits to pharmaceutical companies. This unique service uses a proven, evidence based methodology to quantify and benchmark organisational alignment and quality of execution to create practical action plans to accelerate brand performance. STEM is a global business offering services across 35 countries including the US, EU, Japan and China and its customers include 18 of the top 20 largest pharmaceutical companies.

Buy £84M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-23 sellxpert KG

Speyer, Germany

sellxpert GmbH & Co. KG is a German and Swiss contract sales outsourcing business, based in Speyer, Germany and Basel, Switzerland, respectively. Sellxpert provides innovative sales and marketing services to national and international healthcare and pharmaceutical companies across Germany and Switzerland, complimenting Ashfield’s existing services in the DACH region.

Buy -

Seller(S) 1

SELLER

Daiichi Sankyo

Tokyo, Japan

Category Company
Founded 1899
Sector Life Science
Employees18,726
Revenue 1.60T JPY (2024)
DESCRIPTION

Daiichi Sankyo established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals. Daiichi Sankyo was incorporated in 1899 and is based in Tokyo, Japan.


DEAL STATS #
Overall 2 of 4
Sector (Real Estate) 1 of 1
Type (Divestiture) 2 of 4
State (Pennsylvania) 1 of 1
Country (United States) 1 of 1
Year (2017) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-28 Ambit Biosciences

San Diego, California, United States

Ambit Biosciences Corp. is a biotechnology company focused on oncology; provides drug discovery services to the pharmaceutical industry.

Buy $315M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-01 Daiichi Sankyo Altkirch Sarl

Altkirch, France

Daiichi Sankyo Altkirch Sarl is focused on the manufacturing of raw materials for pharmaceuticals based in Altkirch, France.

Sell -